Pituitary apoplexy in a patient with atrial fibrillation as a side effect of dabigatran treatment

Atrial fibrillation (AF) is the most common heart rhythm abnormality usually present in elderly population significantly increasing the risk for thromboembolic incidents and therefore requiring the long-term treatment with anticoagulant agents. In the last decade, novel ora anticoagulant drugs or NOACs such as dabigatran, apixaban and rivaroxaban have taken over warfarin\u27s role in patients with high risk of blood clothing. They are non peptide, thrombin or coagulation factor Xa inhibitors, consequently patients do not need to control their INR